NovaBridge Biosciences
NovaBridge Biosciences（NBP）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
nbp · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$9.00
Consensus
$9.00
+476.9% upside
Low
$9.00
Median: $9 · Last Close: $1.56
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.50 | ↓ 3.83% |
1-day model range: $1.47–$1.53. Peak: $1.53 (-3.83%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · NBP · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-24 | BTIG | Maintains | Buy→Buy |
| 2025-10-17 | BTIG | Maintains | Buy→Buy |
| 2025-09-10 | BTIG | Maintains | Buy→Buy |
| 2025-09-08 | Needham | Maintains | Buy→Buy |
| 2025-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-20 | Needham | Maintains | Buy→Buy |
| 2025-07-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on NovaBridge Biosciences (NBP) stock. Of the recent 44 rating actions, 0 were upgrades and 0 were downgrades. 11 analysts currently cover NBP.
分析师推荐趋势
NBP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-3.34
EPS Next Year
$-5.02
↑ 50.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast NBP EPS of $-3.34 for the current fiscal year, based on estimates from 1 analysts. The NBP revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NBP 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NBP 的共识目标价为 $9.00（+476.9% 上行空间），分析师共识为 Buy。
NBP 的短期预测（明日）为 $1.50（-3.83%）。 NBP 对 2030 年的预测区间为 $0–$1。
NovaBridge Biosciences 在 NASDAQ 上市，代码 NBP。NBP 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
NBP 预测 · 8 个问题根据 11 位华尔街分析师，NBP 的 12 个月平均目标价为 $9.00，最高 $9.00、最低 $9.00。若有图表，中位目标价可在上方查看。相对当前价 $1.56，隐含约 +476.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.